Leslie Skeith
Overview
Explore the profile of Leslie Skeith including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
62
Citations
320
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Andrew L, Garven A, Taylor T, Bates S, Duffett L, Dubois S, et al.
J Thromb Haemost
. 2025 Mar;
PMID: 40086753
Background: There is a need to better understand barriers to recruitment and participation in randomized controlled trials (RCTs) evaluating postpartum thromboprophylaxis, as previous trials had low recruitment and were not...
2.
Ahmadzadeh Y, Magder L, Magder L, Castro Oliveira De Andrade D, Paredes-Ruiz D, Tektonidou M, et al.
Arthritis Care Res (Hoboken)
. 2025 Feb;
PMID: 39895040
Objective: The objective was to determine the mortality rate as well as the causes and predictors of death in antiphospholipid antibody (aPL)-positive patients with and without antiphospholipid syndrome (APS) classification....
3.
Kobza A, Cardwell F, Elliott S, Gibson P, Soliman N, Skeith L, et al.
Rheumatol Int
. 2025 Jan;
45(2):37.
PMID: 39853441
Little is known about how patients with antiphospholipid syndrome (APS) or antiphospholipid antibodies (aPL) access and trust health information. This research aimed to: describe the sources of information most frequently...
4.
Skeith L, Malinowski A, El-Chaar D, Chan W, Donnelly J, Chauleur C, et al.
Lancet Haematol
. 2025 Jan;
12(2):e109-e119.
PMID: 39827892
Background: Despite the morbidity and mortality of venous thromboembolism, there is little evidence to guide postpartum thromboprophylaxis in patients at moderate risk. We aimed to assess the feasibility of conducting...
5.
Murray A, Campbell E, Clarke A, Barber M, Pannu T, Fritzler M, et al.
Lupus Sci Med
. 2024 Dec;
11(2.
PMID: 39672566
Objectives: Antiphospholipid syndrome (APS) is characterised by the presence of antiphospholipid antibodies (aPLs) and clinical outcomes of thrombosis and/or obstetric morbidity and is associated with systemic lupus erythematosus (SLE). IgG...
6.
Skeith L, Bates S
Hematology Am Soc Hematol Educ Program
. 2024 Dec;
2024(1):644-651.
PMID: 39644023
Hormonal contraceptive therapy (estrogens and/or progestogens) includes different formulations associated with varying venous thromboembolism (VTE) risks. The thrombogenicity of combined hormonal contraceptives (CHCs) is due at least in part to...
7.
Skeith L, James P, Kouides P, Uminski K, Duffett L, Jackson S, et al.
J Thromb Haemost
. 2024 Oct;
23(2):429-439.
PMID: 39454883
Background: While bleeding around pregnancy is well described in von Willebrand disease (VWD), the risk of pregnancy loss is less certain. Objectives: We aimed to describe the frequency of pregnancy...
8.
Cardwell F, Kobza A, Elliott S, Gibson P, Soliman N, Skeith L, et al.
Lupus
. 2024 Jul;
33(10):1043-1058.
PMID: 39045728
Objective: Substantial morbidity and mortality affect those with antiphospholipid antibodies (aPLs) and antiphospholipid syndrome (APS), yet patient experiences remain poorly understood. This research investigated patient experiences of aPL/APS diagnosis; effects...
9.
Bhangu G, Murray A, Qayyum A, Goumeniouk N, Goodacre S, Hunt B, et al.
Thromb Res
. 2024 Feb;
236:108-116.
PMID: 38422980
Background: The risk of venous thromboembolism (VTE) is increased postpartum and contributes to important morbidity and mortality. While there have been advances in evaluating diagnostic algorithms for suspected VTE during...
10.
Yelnik C, Erton Z, Drumez E, Cheildze D, de Andrade D, Clarke A, et al.
Semin Arthritis Rheum
. 2024 Jan;
65:152347.
PMID: 38185079
Background: Long-term anticoagulant therapy is generally recommended for thrombotic antiphospholipid syndrome (TAPS) patients, however it may be withdrawn or not introduced in routine practice. Objectives: To prospectively evaluate the risk...